[1] Sengoku R. Aging and Alzheimer's disease pathology[J]. Neuropathology, 2020, 40(1): 22-29. [2] Xia X, Jiang Q, McDermott J, et al. Aging and Alzheimer's disease: comparison and associations from molecular to system level[J]. Aging Cell, 2018, 17(5): e12802. [3] Liu B, Liu J, Shi J S. SAMP8 mice as a model of age-related cognition decline with underlying mechanisms in Alzheimer's disease[J]. J Alzheimers Dis, 2020,75(2):385-395. [4] Akiguchi I, Pallàs M, Budka H, et al. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions[J]. Neuropathology, 2017,37(4):293-305. [5] 马登磊,张旭,张丽,等. 山茱萸环烯醚萜苷对创伤性脑损伤大鼠认知功能及tau蛋白磷酸化的影响[J]. 首都医科大学学报,2020,41(3): 397-402. [6] Ma D, Zhu Y, Li Y, et al. Beneficial effects of cornel iridoid glycoside on behavioral impairment and senescence status in SAMP8 mice at different ages[J]. Behav Brain Res, 2016, 312: 20-29. [7] Ma D, Li Y, Zhu Y, et al. Cornel iridoid glycoside ameliorated Alzheimer's disease-like pathologies and necroptosis through RIPK1/MLKL pathway in young and aged SAMP8 mice[J]. Evid Based Complement Alternat Med, 2021, 2021: 9920962. [8] 马登磊,张兰,李林. 脑外伤动物模型认知障碍评价方法研究进展[J]. 中国康复理论与实践,2015,21(1): 65-68. [9] Akiguchi I, Pallàs M, Budka H, et al. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda's legacy and future directions[J]. Neuropathology, 2017, 37(4): 293-305. [10]Wang F, Chen H, Sun X. Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice[J]. Neurosci Lett, 2009, 454(3): 212-217. [11]Zhang Z, Yang J, Liu C, et al. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice[J]. Pharmacol Res, 2019, 139:512-523. [12]Del V J, Duran-Vilaregut J, Manich G, et al. Early amyloid accumulation in the hippocampus of SAMP8 mice[J]. J Alzheimers Dis, 2010, 19(4): 1303-1315. [13]Huang J, Wu D, Wang J, et al. Effects of Panax notoginseng saponin on α, β, and γ secretase involved in Aβ deposition in SAMP8 mice[J]. NeuroReport, 2014, 25(2): 89-93. [14]Puigoriol-Illamola D, Leiva R, Vázquez-Carrera M, et al. 11β-HSD1 inhibition rescues samp8 cognitive impairment induced by metabolic stress[J]. Mol Neurobiol, 2020, 57(1):551-565. [15]Kitaoka K, Shimizu N, Ono K, et al. The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice[J]. Neuropharmacology, 2013, 72: 58-65. [16]Kurochkin I V, Guarnera E, Berezovsky I N. Insulin-degrading enzyme in the fight against Alzheimer's disease[J]. Trends Pharmacol Sci, 2018, 39(1): 49-58. [17]Rajmohan R, Reddy P H. Amyloid-Beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer's disease neurons[J]. J Alzheimers Dis, 2017, 57(4): 975-999. [18]Lian W W, Zhou W, Zhang B Y, et al. DL0410 ameliorates cognitive disorder in SAMP8 mice by promoting mitochondrial dynamics and the NMDAR-CREB-BDNF pathway[J]. Acta Pharmacol Sin, 2021,42(7):1055-1068. [19]Harris K P, Littleton J T. Transmission, development, and plasticity of synapses[J]. Genetics, 2015, 201(2): 345-375. [20]Diering G H, Huganir R L. The AMPA receptor code of synaptic plasticity[J]. Neuron, 2018, 100(2): 314-329. [21]Zalcman G, Federman N, Romano A. CaMKII isoforms in learning and memory: localization and function[J]. Front Mol Neurosci, 2018, 11:445. [22]Cai Q, Zeng M, Wu X, et al. CaMKIIα-driven, phosphatase-checked postsynaptic plasticity via phase separation[J]. Cell Res, 2021, 31(1): 37-51. [23]曹丽,石岩硕,庞国勋.谷氨酰胺在神经系统疾病的临床应用研究进展[J].解放军医药杂志,2020,32(6):113-116. |